Correlation Between Eli Lilly and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Crispr Therapeutics AG, you can compare the effects of market volatilities on Eli Lilly and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Crispr Therapeutics.
Diversification Opportunities for Eli Lilly and Crispr Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Eli and Crispr is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Eli Lilly i.e., Eli Lilly and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Eli Lilly and Crispr Therapeutics
Considering the 90-day investment horizon Eli Lilly and is expected to generate 0.31 times more return on investment than Crispr Therapeutics. However, Eli Lilly and is 3.26 times less risky than Crispr Therapeutics. It trades about 0.43 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.08 per unit of risk. If you would invest 80,361 in Eli Lilly and on November 29, 2024 and sell it today you would earn a total of 11,140 from holding Eli Lilly and or generate 13.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eli Lilly and vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Eli Lilly |
| Crispr Therapeutics |
Eli Lilly and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eli Lilly and Crispr Therapeutics
The main advantage of trading using opposite Eli Lilly and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Eli Lilly vs. Johnson Johnson | Eli Lilly vs. Bristol Myers Squibb | Eli Lilly vs. AbbVie Inc | Eli Lilly vs. Pfizer Inc |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |